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Abstract
Background: Long-term patients with diabetes and peripheral neuropathy show altered foot
biomechanics and abnormal foot loading. This study aimed at assessing muscle performance and
ankle mobility in such patients under controlled conditions.
Methods: Forty six long-term diabetes patients with (DN) and without (D) peripheral neuropathy,
and 21 controls (C) were examined. Lower leg muscle performance and ankle mobility were
assessed by means of a dedicated equipment, with the patient seated and the examined limb
unloaded. 3D active ranges of motion and moments of force were recorded, the latter during
maximal isometric contractions, with the foot blocked in different positions.
Results:  All patients showed reduced ankle mobility. In the sagittal and transversal planes
reduction vs C was 11% and 20% for D, 20% and 21% for DN, respectively.
Dorsal-flexing moments were significantly reduced in all patients and foot positions, the highest
reduction being 28% for D and 37% for DN. Reductions of plantar-flexing moments were in the
range 12–15% for D (only with the foot blocked in neutral and in dorsal-flexed position), and in the
range 10–24% for DN. In all patients, reductions in the frontal and transversal planes ranged 14–
41%.
Conclusion: The investigation revealed ankle functional impairments in patients with diabetes,
with or without neuropathy, thus suggesting that other mechanisms besides neuropathy might
contribute to alter foot-ankle biomechanics. Such impairments may then play a role in the
development of abnormal gait and in the onset of plantar ulcers.
Background
Diabetic peripheral neuropathy is the main cause of sen-
sory and motor deficit of the feet: as a result, motor con-
trol of gait is compromised, nerve degeneration may cause
muscle weakness and atrophy, and plantar ulcers may
occur [1,2].
A further severe complication of diabetes, namely hyperg-
lycaemia, should be also accounted for in the analysis of
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gait alterations. As a point of fact, hyperglycaemia alone
promotes glycosylation of proteins, resulting in the accu-
mulation of advanced glycosylation end-products in tis-
sues. Damaging events will then ensue in almost every
tissue and organ [3]. With respect to structures which are
directly involved in gait, abnormal thickness of plantar
fascia and Achilles tendon has been measured in long-
term patients [4].
Several authors have dealt with the impairment of joint
motion at the foot-ankle complex in the presence of dia-
betes. A general decreasing trend was observed in the
range of motion, especially in flexion-extension move-
ments [5,6]. Hypotheses were formulated about altera-
tions in the structure of cartilages and capsules [7] which
might interfere with joint mobility [5,8,9]. Studies were
also conducted to investigate the role of muscular deficits
in patients with diabetes [10-13]. Most in vivo studies ana-
lysed muscle performance under isokinetic conditions,
both active [14-18] or passive [5,6]. In a recent study [13]
on long-term diabetic patients under active isokinetic con-
ditions, Andreassen highlighted a progressive muscle
weakening, the rate of which was strictly related to the
severity of neuropathy. Whereas in patients without neu-
ropathy no significant change was found. Andersen [18]
showed a significant muscle strength reduction in long-
term patients with and without neuropathy; however, the
data referring to non neuropathic patients were not sepa-
rately reported in the paper. Since all the above measure-
ments had been recorded during isokinetic exercises,
other factors like inertia of the masses might have affected
the measurements and masked some further findings.
Manual muscle testing (MMT) – a well known clinical
method to assess muscle strength – has also been used to
qualitatively assess muscle weakness in both ankle and
knee of patients with diabetic neuropathy. However, its
reliability is still doubtful; more specifically, it was found
to significantly underestimate forces when compared with
isokinetic dynamometry [19]. Thus, it does not seem an
accurate method to investigate muscle performance better
in long-term patients.
The present study aimed at accurately characterising the
main functional alterations of the foot-ankle complex -
namely joint mobility and muscle performance- in 46
long-term patients, 19 with and 27 without neuropathy,
under well controlled conditions. An ankle dynamometer
was used to assess: i) ankle mobility under active,
unloaded conditions; ii) muscle performance of the main
leg muscles during voluntary maximal isometric contrac-
tions.
From a clinical point of view, the study aimed at a deeper
understanding of as many factors as possible which con-
cur to alterations of gait parameters in the presence of
long-term diabetes. Hopefully, the findings of the study
may support the design of early rehabilitative paths aimed
at preventing the onset of ulcerative processes.
Methods
Patient recruitment
Long-term patients with diabetes were recruited from the
Outpatients Clinic of the University of Tor Vergata (Rome,
Italy). Sixty one patients matched the inclusion criteria
and were enrolled. Briefly, inclusion criteria were: age < 70
years; no history of peripheral vascular disease (ankle bra-
chial pressure index > 0.85 and no symptoms of intermit-
tent claudication); absence of neurological diseases but
for those of diabetic aetiology; absence of muscular, skel-
etal or rheumatic disease; absence of any major or minor
amputation; absence of Charcot neuro-arthropathy due to
previous traumas [20]; diabetes duration > 7 years. The
level of neuropathy was assessed by using the Neuropathy
Disability Score (NDS) [21] and the Vibration Perception
Threshold (VPT) [20]. For the purpose of this study, the
presence of neuropathy was defined by NDS > 5 and VPT
> 25 V [22]. Callouses, if any, were removed before meas-
urements. Fifteen of the recruited patients had previously
developed plantar ulcers that had healed at least three
months before examination. Even though they were
assessed and accounted for in other parts of the study, the
analysis of their data is beyond the scope of the present
investigation, and not discussed in the following. The
remaining 46 long-term patients with diabetes were
divided into group D (27 patients without neuropathy)
and group DN (19 patients with neuropathy).
Twenty one healthy volunteers were screened and
included in the study for comparison. They matched the
above inclusion criteria but for specific, diabetes-related
items. Their histories and the objective clinical examina-
tion excluded neuro-muscular or skeletal pathologies that
might have influenced their gait.
Patients and healthy volunteers were recruited homogene-
ously as per sex, age, body mass index and occupation.
Activity levels were only qualitatively assessed. Attention
was paid to verify that both patients and healthy volun-
teers were routinely active and did not practice sports at a
professional level.
All patients and healthy volunteers gave their informed
written consent in accordance with the principles of Hel-
sinki Declaration. The study was approved by the Ethics
Committee of the University of Tor Vergata (Rome, Italy).
The ankle measurement device
The ankle device used to quantify joint mobility and mus-
cular function had been designed and constructed at theBMC Musculoskeletal Disorders 2008, 9:99 http://www.biomedcentral.com/1471-2474/9/99
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authors' lab [23]. Briefly, it consists of a mechanical sys-
tem which accurately measures linear and angular dis-
placements of the foot with respect to the shank or, in case
any rotation is blocked, moments of force at the foot-
ankle complex expressed during isometric contractions.
The device is accurately balanced, and the patient works
under almost unloaded conditions. Figure 1 shows a
sketch of the device. The prototype used in the present
study is shown in Figure 2. Moments of force can be meas-
ured in any desired fixed position of the foot with respect
to the shank. Measurement ranges are ± 250 Nm for flex-
ion-extension, and ± 20 Nm for both inversion-eversion
and internal-external rotation. The overall measuring
chain, based on accurately calibrated strain gauge trans-
ducers, has high linearity (R2 = 0.993) and sensitivity
(0.02–0.71 Volt/Nm).
Angular displacements can be measured in all three
planes of the reference system by means of commercial,
high-precision angular potentiometers (sensitivity 0.1
Volt/°). Measurement ranges are ± 100° for flexion-exten-
sion, and ± 50° for both inversion-eversion and internal-
external rotation. All output signals are low-pass filtered at
10 Hz before being processed.
Measurement protocol
During the measurement session the patient was asked to
seat on an adjustable chair rigidly fixed to the wooden
platform of the measurement device. His/her right shank
was aligned to the first link of the device – previously
rotated by +20° with respect to the horizontal plane – and
the foot was fixed to the last link of the device: the forefoot
was blocked with velcro stripes; the rearfoot was blocked
by means of an aluminium block and an interposed
polymethylsiloxane mould previously modelled on the
patient's calcaneus. This blocking system guarantees for
the free movement of the foot in the three planes. The foot
was blocked at 90° with respect to the shank in the sagittal
plane, and at 0° in the other two planes (frontal and
Draft of the ankle measurement device Figure 1
Draft of the ankle measurement device. A. Ankle measurement device (7 link, 6 DOF* mechanical chain); link 0 is solid 
with the patient's shank, link 6 with his/her foot. B. 2 DOF* metallic fork to maintain the knee in a fixed position. C. 3 DOF* 
adjustable seat, with bowable back. (a: flexion-extension axis; b: pronation-supination axis; c: internal-external rotation axis). * 
DOF = Degrees Of FreedomBMC Musculoskeletal Disorders 2008, 9:99 http://www.biomedcentral.com/1471-2474/9/99
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transversal). The knee was tied to a fork-shaped support
rigidly fixed to the base of the device.
The patients were first trained to perform and maintain
maximal isometric contractions starting from resting con-
dition. Then they were asked to perform a sequence of iso-
metric maximal contractions – one for each measurement
position – to produce moments around each axis, in both
directions. Each contraction lasted for 10s and was fol-
lowed by 90s of rest. The execution of the requested task
was monitored by means of a surface EMG device. When
abnormal muscle activity was observed before or during
the contraction, the patient was asked to repeat the task
after 90s of rest. Moments of force around the medio-lat-
eral axis were further investigated by repeating the same
exercise with the foot blocked at +15° and at +30° of
plantar flexion, and at -15° of dorsal flexion. As regards
active angular excursions, they were acquired sequentially
in the directions of flexion-extension, internal-external
rotation and inversion-eversion. Subjects were asked to
perform slow cycles for a period of approximately 10s in
each plane. They worked under almost unloaded condi-
tions. No aid was supplied by the operator. A total of 6 or
7 cycles per plane were performed. The whole measure-
ment sequence was repeated for the left leg.
Data analysis
Data from right and left foot were processed separately for
each patient. Maximum moments of force were normal-
ised with respect to body weight and body height and
expressed as %Nm. This normalisation was chosen to take
into account not only the dependence of muscle length
and moment arm on patient's height, but also their even-
tual dependence on his/her body mass.
Absolute values were used for angular excursions; the
absolute maximum value in each direction of each plane
(6 values per foot) was included in the study.
Once verified that they were normally distributed (chi-
square test), basic parametric statistics (ANOVA with Bon-
ferroni correction, p < 0.05) was applied to the above data
and to the anthropometric and baseline clinical data of
patients and volunteers.
Results
The demographic data of the recruited population (Table
1) did not show significant inter-group differences as for
age, metabolic control or diabetes duration, being the last
two parameters only related to D and DN groups [22].
Foot-ankle joint mobility showed an overall reduction in
the sagittal and transversal planes (Table 2). Both groups
of patients showed significant reductions (ANOVA with
Bonferroni correction, p < 0.05) with respect to the con-
The ankle measurement device Figure 2
The ankle measurement device. A. Prototype of the 
ankle measurement device. B. Positioning phase of the right 
leg of a patient: the knee has already been fixed to the metal-
lic fork; the forefoot has already been fixed to link 6 of the 
device; the rearfoot has been inserted in the ad hoc mould, 
and it only needs to be further fixed with Velcro stripes; the 
shank has already been aligned with link 0 of the device. C. 
Detail of a completed foot fixing.BMC Musculoskeletal Disorders 2008, 9:99 http://www.biomedcentral.com/1471-2474/9/99
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trol group, the only exception being plantar flexion in D
patients (t = 2.222, critical t value = 2.355).
A decreasing trend was observed with respect to muscle
function (Tables 3 and 4). D and DN patients showed
reductions of normalised moments of force in all planes,
directions, and foot positions. For both groups the reduc-
tions were significant as for: i) dorsal flexing moments
(sagittal plane) measured with the foot blocked at 0°,
+15° and +30° (Table 3); ii) internal rotation in the trans-
versal plane (external rotation significantly reduced for
DN patients only); iii) eversion (frontal plane; Table 4).
DN patients also showed statistical evidence of muscular
impairment with respect to D patients as for plantar flex-
ing moments exerted with the foot blocked at +15° and
+30° (Table 3).
Discussion
The experimental data of the present study showed a cer-
tain reduction of muscle performance at the foot-ankle
complex in both groups of patients, DN and D, with and
without neuropathy, respectively. In the sagittal plane the
major impairment was found to be associated with the
action of the dorsal flexors rather than the extensors of the
ankle. The decrease ranged 10 to 28% in D patients and
18 to 37% in DN patients. In both groups the highest
reduction was recorded with the foot blocked at +15° of
plantar flexion.
Table 1: Patients' baseline characteristics
CD D N
Patients 21 27 19
Male/Female 13/8 19/8 10/9
Age (years)  mean (SD) 56.6 (11.8) 52.7 (12.7) 53.7 (10.4)
BMI (Kg/m2)  mean (SD) 25.0 (3.1) 25.3 (3.4) 27.0 (4.9)
Type 1/Type 2 - 8/19 9/10
Diab. Duration (years)  mean (SD) - 15.1 (9.3) 19.4 (9.3)
HbA1c (%) °  mean (SD) - 7.5 (1.5) 7.8 (1.8)
VPT toe (Volt)  mean (SD) 5.3 (2.1) 14.7 (5.7) 31.5 (7.6) *
NDS 0 3.8 [0–5] 6.95 [6–8]*
Retinopathy (a/b/p) - 24/0/3 9/5/5
Nephropathy (a/m/M) - 26/1/0 16/2/1
C: controls; D: diabetic patients without neuropathy; DN: diabetic patients with neuropathy
SD: standard deviation
* D vs DN; Student's t-test, p < 0.05
a/b/p = absent, background, proliferative;
a/m/M = absent/microalbuminuria/macroalbuminuria
° normal range: 4.3 – 5.9%.
Table 2: Active joint mobility of the foot-ankle complex in all reference planes: columns 2–4 show mean values and standard 
deviations, expressed in degrees; columns 5–7 show t values obtained from the comparisons of C vs D, C vs DN and D vs DN (ANOVA 
with Bonferroni correction, p < 0.05, t critical value = 2.355).
Mean value (SD) t value of multiple comparisons
CDD N C   vs DC   vs DN D vs DN
Dorsal flexion (p = 0.000) 34.4(8.3) 29.8 (6.4) * 27.3 (5.8) * 3.034 4.355 1.658
Plantar flexion (p = 0.000) 40.1 (7.0) 36.4 (5.1) 32.4 (7.1) * 2.222 4.209 2.291
Range (p = 0.000) 74.6 (13.6) 66.2 (11.3) * 59.6 (10.1) * 3.011 4.994 2.302
External rotation (p = 0.003) 41.8 (7.1) 34.6 (13.5) * 35.0 (10.0) * 3.222 2.779 0.192
Internal rotation (p = 0.000) 39.0 (7.4) 30.1 (14.6) * 28.9 (10.1) * 3.784 3.925 0.473
Range (p = 0.000) 80.8 (12.3) 64.7 (27.4) * 64.0 (18.3) * 3.710 3.553 0.159
Eversion (p = 0.018) 15.3 (5.1) 16.2 (6.8) 12.4 (4.9) § 0.688 2.044 2.830
Inversion (p = 0.707) 30.8 (6.9) 30.0 (10.4) 31.5 (8.1) - - 0.820
Range (p = 0.613) 46.2 (9.5) 46.2 (14.4) 43.9 (11.0) - - 0.901
C: controls; D: diabetic patients without neuropathy; DN: diabetic patients with neuropathy
SD: standard deviation
* C vs D or C vs DN (ANOVA with Bonferroni correction, p < 0.05 and t > 2.355)
§D vs DN (ANOVA with Bonferroni correction, p < 0.05 and t > 2.355)BMC Musculoskeletal Disorders 2008, 9:99 http://www.biomedcentral.com/1471-2474/9/99
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Some changes in muscle structure and impairments in
muscle function have been observed in presence of neu-
ropathy and reported in the literature: i) muscle atrophy
was measured at the level of the lower limb [10,11]; ii)
muscle volume was found to be altered in long-term
patients with diabetes and neuropathy, but preserved in
the absence of neuropathy [10]; iii) a certain worsening in
muscle performance was observed in patients with long-
term diabetes [18] and peripheral neuropathy [13]. Most
of the above studies were in a good agreement with the
hereby reported findings as far as neuropathic patients are
concerned. Some disagreement was found with respect to
the hereby stated muscle weakness of long-term, non-neu-
ropathic diabetic patients. The study by Andersen [18] did
show a significant muscle strength reduction in the overall
population of long-term patients, with and without neu-
ropathy; however, the data referring to non neuropathic
patients were not separately reported in the paper, there-
fore it was not possible to make direct comparisons.
The hereby calculated greater percentages of muscle
strength reduction might be due to some differences in
measurement instrumentation and procedures, the most
important being the use of an isometric instead of an iso-
kinetic test device. When performing isokinetic tests the
patient has to work at a fixed angular velocity; this condi-
tion, however, is rigorously true for a limited time period
of the exercise. At the beginning, in fact, a certain acceler-
ation is allowed to the leg, until the isokinetic device
reaches the selected value of velocity. Similarly, a certain
deceleration is allowed in the final part of the exercise. The
length of such "uncontrolled" phases depends on the
established angular velocity: the higher the velocity, the
longer the acceleration and deceleration phases. As a
result, several variables, like inertial and gravitational
effects, and the selected angular velocity may play a role in
the overall recorded moment of force. In the present study
the use of isometric and almost unloaded working condi-
tions might have helped subjects do the task under better
Table 3: Dorsal/plantar flexing moments at the ankle, normalised with respect to body weight * height.
Mean value (SD) t value of multiple comparisons
CDD N C   vs DC   vs DN D vs DN
Plantar flexion at -15° (p = 0.205) 3.84 (1.27) 3.27 (1.99) 3.31 (1.53) 1.465 - -
Plantar flexion at 0° (p = 0.328) 3.40 (1.36) 2.99 (1.50) 3.05 (1.26) 1.432 - -
Plantar flexion at +15° (p = 0.009) 2.49 (1.14) 2.70 (1.40) 1.93 (0.84) § 0.863 2.115 3.075
Plantar flexion at +30° (p = 0.011) 1.40 (0.81) 1.50 (0.70) 1.06 (0.53) § 0.699 2.185 2.990
Dorsal flexion at -15° (p = 0.231) 2.40 (1.26) 2.17 (1.04) 1.96 (1.15) - 1.718 -
Dorsal flexion at 0° (p = 0.002) 3.14 (1.34) 2.38 (1.31) * 2.21 (1.09) * 2.928 3.292 0.636
Dorsal flexion at +15° (p = 0.000) 3.38 (1.30) 2.45 (1.28) * 2.13 (1.09) * 3.658 4.518 1.223
Dorsal flexion at +30° (p = 0.000) 2.76 (0.85) 2.17 (0.99) * 1.88 (0.83) * 3.172 4.348 1.515
Mean values and standard deviations are expressed in %Nm. Moments are referred to four angular positions in the sagittal plane, with the foot 
blocked at: 15° of dorsal flexion (-15°); 0° (neutral position); 15° and 30° of plantar flexion (+15°; +30°). Columns 2–4 show mean values and 
standard deviations; columns 5–7 show t values obtained from the comparisons of C vs D, C vs DN and D vs DN (ANOVA with Bonferroni 
correction, p < 0.05, t critical value = 2.355).
C: controls; D: diabetic patients without neuropathy; DN: diabetic patients with neuropathy
SD: standard deviation
* C vs D or C vs DN (ANOVA with Bonferroni correction, p < 0.05 and t > 2.355)
§D vs DN (ANOVA with Bonferroni correction, p < 0.05 and t > 2.355)
Table 4: Internal/external torques and inversion/eversion moments at the ankle, normalised with respect to body weight*height.
Mean value (SD) t value of multiple comparisons
CDD N C   vs DC   vs DN D vs DN
Internal rotation (p = 0.000) 1.12 (0.53) 0.83 (0.65) * 0.66 (0.38) * 2.575 3.753 1.467
External rotation (p = 0.003) 1.32 (0.50) 1.07 (0.69) 0.87 (0.47) * 2.105 3.482 1.636
Inversion (p = 0.278) 0.93 (0.36) 0.80 (0.48) 0.79 (0.49) - 1.393 -
Eversion (p = 0.000) 0.73 (0.25) 0.55 (0.28) * 0.46 (0.25) * 3.332 4.593 1.619
Mean values and standard deviations are expressed in %Nm. Moments are referred to neutral position. Columns 2–4 show mean values and 
standard deviations; columns 5–7 show t values obtained from the comparisons of C vs D, C vs DN and D vs DN (ANOVA with Bonferroni 
correction, p < 0.05, t critical value = 2.355).
C: controls; D: diabetic patients without neuropathy; DN: diabetic patients with neuropathy
SD: standard deviation
* C vs D or C vs DN (ANOVA with Bonferroni correction, p < 0.05 and t > 2.355)BMC Musculoskeletal Disorders 2008, 9:99 http://www.biomedcentral.com/1471-2474/9/99
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controlled conditions, thus highlighting even smaller dif-
ferences in muscle performance, as it was for long-term,
non neuropathic patients. Moreover, the assessment of
muscle performance in the other two planes of the ana-
tomical reference system showed that moments of force
were significantly reduced also with respect to internal
rotation and, most importantly, with respect to eversion,
which confirms a significant muscular impairment of the
ankle dorsal flexors. A reasonable explanation was the
weaker performance of the dorsal flexors with respect to
the extensors, more evident in D than in DN patients. As
reported in [21], Achille's Tendon and Plantar Fascia
showed abnormal thickness in D patients too. Thus, the
hypothesis is that their joint action may mechanically
result in a higher resistance to dorsal flexing moments.
As for the active joint mobility, the present study revealed
its overall reduction in all planes and directions of move-
ment, also evident in D patients with the only exception
of the frontal plane. This finding is in agreement with the
literature [5,6], and seems to confirm the hypothesis that
the concurrent alterations of structure and coefficient of
elasticity of cartilages and capsule may limit the active
range of motion of long-term patients with diabetes.
To formulate a reasonable hypothesis about the func-
tional impairment, the present study has demonstrated
for patients without neuropathy, that moments of force
may be conceived as the resultant of passive and active
moments. A recent study [5] showed that a significant
increase in the viscous component of passive ankle joint
movement occurs in long-term diabetic patients, thus a
certain percentage of the overall decrease in the moment
of force may be ascribed to muscle atrophy induced by
abnormal viscoelastic behaviour of passive motion. If
present, this phenomenon is a direct consequence of tis-
sue damages due to hyperglycaemia, and it is quite inde-
pendent from neuropathy. Obviously, a major
contribution to moment of force decrease is due to muscle
atrophy directly related to nerve conduction degenera-
tion, which is a direct consequence of neuropathy.
Together with alterations of cartilages, ligaments and ten-
dons [21], all these factors may explain the worsening of
muscle performance, and may play a critical role in the
concurrent – and strictly related – limitation of ankle
active joint mobility, even in long-term patients without
neuropathy.
The data reported in the present study were collected
under controlled conditions altogether different from
normal gait, i.e., with the patient seated and the foot
unloaded. However, the hypothesis is hereby formulated
that the resultant functional impairment and the adverse
action of gravity may combine to seriously impair the bio-
mechanics of gait. More specifically, they may worsen the
management of both the landing and the propulsive
phase of gait: in the former phase the foot is dorsi-flexed
and the action of ankle flexors is required to slow down
the leg and stabilise the foot before heel strike; in the latter
phase the foot is plantar-flexed and the ankle extensors
must deliver enough energy to correctly accelerate forward
the centre of mass [24].
Conclusion
Measurement equipments, protocols and methodologies
were set up and specialised in the present study to assess
the function of the diabetic foot-ankle complex under
well controlled conditions, with the patient seated and
the foot unloaded. The study focused on long-term
patients with diabetes, with and without neuropathy.
As expected, and in agreement with the specialised litera-
ture, a certain reduction of 3D ranges of motion and
moments of force was found in long-term patients with
diabetes and peripheral neuropathy. Interestingly
enough, significant functional impairments were found in
the absence of neuropathy too.
In conclusion, the described foot-ankle functional assess-
ment under strictly controlled conditions seems to be an
accurate and effective means to highlight limitations in
muscle performance and ankle joint mobility in long-
term patients – even before the onset of neuropathy –.
This suggests that other mechanisms besides neuropathy
might contribute to alter foot-ankle biomechanics. Such
mechanisms, and their role in the development of abnor-
mal gait and in the onset of plantar ulcers, certainly
deserve further investigation.
From a clinical point of view, the findings of the present
study may help design ad hoc rehabilitative paths, in order
to maintain an adequate level of gait performance in the
presence of long-term diabetes, thus preventing excessive
loading of foot tissues at risk of ulceration.
Competing interests
The authors declare that they have no competing interests.
Authors' contributions
CG led the design and implementation of the study, and
performed the data analysis. ED participated in the design
of the measurement protocol and in data collection and
interpretation. SC participated in data collection and
processing. VM and LU participated in the design of the
study and in data interpretation. All authors actively par-
ticipated in drafting the manuscript. They all read and
approved the final manuscript.Publish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
BMC Musculoskeletal Disorders 2008, 9:99 http://www.biomedcentral.com/1471-2474/9/99
Page 8 of 8
(page number not for citation purposes)
Acknowledgements
The authors thank all the patients and healthy volunteers who participated 
in the study. Special thanks are due to Ms. Monica Brocco for the linguistic 
revision of the manuscript.
References
1. Boulton AJM: Clinical presentation and management of dia-
betic neuropathy and foot ulceration.  Diab Med 1991,
8:S52-S57.
2. Andersen H, Gadeberg PC, Brock B, Jakobsen J: Muscular atrophy
in diabetic neuropathy: a stereological magnetic resonance
imaging study.  Diabetologia 1997, 40:1062-1069.
3. Barbagallo M, Novo S, Licata G, Resnick LM: Diabetes, hyperten-
sion and atherosclerosis: pathophysiological role of intracel-
lular ions.  Int Angiol 1993, 12(4):365-370.
4. D'Ambrogi E, Giacomozzi C, Macellari V, Uccioli L: Abnormal foot
function in diabetic patients: the altered onset of Windlass
Mechanism.  Diab Med 2005, 22(12):1713-1719.
5. Hajrasouliha AR, Tavakoli S, Esteki A, Nafisi S: Abnormal viscoelas-
tic behaviour of passive ankle joint movement in diabetic
patients: an early or a late complication?  Diabetologia 2005,
48:1225-1228.
6. Salsich GB, Mueller MJ, Sahrmann SA: Passive ankle stiffness in
subjects with diabetes and peripheral neuropathy versus an
age-matched comparison group.  Phys Ther 2000, 80(4):352-362.
7. Crisp AJ, Heatcoate JG: Connettive tissue abnormalities in dia-
betes mellitus.  J R Coll Physicians Lond 1984, 18:132-140.
8. Delbridge L, Ellis CS, Robertson K: Nonenzymatic glycosylation
of keratin from the stratum corneum of the diabetic foot.  Br
J Dermatol 1985, 112:547-554.
9. Delbridge L, Perry P, Marr S, Arnold N, Yue DK, Turtle JR, Reeve TS:
Limited jont mobility in the diabetic foot: relationship to
neuropathic ulceration.  Diabet Med 1988, 5(4):333-337.
10. Andersen H, Gjerstad MD, Jakobsen J: Atrophy of Foot Muscles.
A measure of diabetic neuropathy.  Diabetes Care 2004,
27:2382-2385.
11. Bus SA, Yang QX, Wang JH, Smith MB, Wunderlich R, Cavanagh PR:
Intrinsic muscle atrophy and toe deformity in the diabetic
neuropathic foot: a magnetic resonance imaging study.  Dia-
betes Care 2002, 25:1444-1450.
12. Van Schie CHM, Vermili C, Carrington AL, Boulton AJM: Muscle
weakness and foot deformities in diabetes relationship to
neuropathy and foot ulceration in Caucasian diabetic men.
Diabetes Care 2004, 27:1668-1673.
13. Andreassen CS, Jakobsen J, Andersen H: Muscle weakness: a pro-
gressive late complication in diabetic distal symmetric
polyneuropathy.  Diabetes 2006, 55:806-812.
14. Andersen H, Poulsen PL, Mogensen CE, Jakobsen J: Isokinetic mus-
cle strength in long-term iddm patients in relation to dia-
betic complications.  Diabetes 1996, 45:440-445.
15. Andersen H, Mogensen PH: Disordered mobility of large joints
in association with neuropathy in patients with long-standing
insulin-dependent diabetes mellitus.  Diab Med 1997,
14:221-227.
16. Andersen H, Jakobsen J: Motor function in diabetes.  Diab Rev
1999, 7(4):326-341.
17. Salsich GB, Mueller MJ, Hastings MK, Sinacore DR, Strube MJ, Johnson
JE: Effect of Achilles tendon lengthening on ankle muscle per-
formance in people with diabetes mellitus and a neuropathic
plantar ulcer.  Phys Ther 2005, 85(1):34-43.
18. Andersen H, Nielsen S, Mogensen CE, Jakobsen J: Muscle Strength
in Type 2 Diabetes.  Diabetes 2004, 53:1543-1548.
19. Andersen H, Jakobsen J: A comparative study of isokinetic
dynamometry and manual muscle testing of ankle dorsal and
plantar flexors and knee extensors and flexors.  Eur Neurol
1997, 37(4):239-242.
20. Boulton AJM, Kubrusly D, Bowser JH, Gadia MT, Quintero L, Becker
DM, Skyler JS, Sonsenko JM: Impaired vibratory perception and
diabetic foot ulceration.  Diab Med 1986, 3:335-337.
21. Giacomozzi C, D'Ambrogi E, Uccioli L, Macellari V: Does the thick-
ening of Achilles tendon and plantar fascia contribute to the
alteration of diabetic foot loading?  Clin Biomech 2005,
20(5):532-539.
22. Uccioli L, Caselli A, Giacomozzi C, Macellari V, Giurato L, Lardieri L,
Menzinger G: Pattern of abnormal tangential forces in the dia-
betic neuropathic foot.  Clin Biomech 2001, 16(5):446-454.
23. Giacomozzi C, Cesinaro S, Basile F, De Angelis G, Giansanti D, Mac-
cioni G, Masci E, Panella A, Paolizzi M, Torre M, Valentini P, Macellari
V: A measurement device for the ankle joint kinematic and
dynamic characterisation.  Med Biol Eng Comput 2003,
41(4):486-493.
24. Giacomozzi C, Caselli A, Macellari V, Giurato L, Lardieri L, Uccioli L:
Walking strategy in diabetic patients with peripheral neu-
ropathy.  Diabetes Care 2002, 25(8):1451-1457.
Pre-publication history
The pre-publication history for this paper can be accessed
here:
http://www.biomedcentral.com/1471-2474/9/99/prepub